Beijing Luhe Hospital
36
3
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
5.6%
2 terminated/withdrawn out of 36 trials
75.0%
-11.5% vs industry average
8%
3 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
Role: collaborator
Chronic Kidney Disease and Metabolic Disorders in the Elderly
Role: collaborator
Glycemic Targets During CPB in Elderly Diabetes
Role: collaborator
Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
Role: collaborator
Effects of Lactulose on Gut Microbiota and Metabolism in Diabetic Constipated Patients
Role: collaborator
Distal Radial Access for Primary PCI in STEMI Patients to Prevent RAO
Role: lead
Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels
Role: collaborator
Basilar Artery Occlusion Chinese Endovascular Trial
Role: collaborator
Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study
Role: collaborator
Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
Role: lead
A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )
Role: collaborator
A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA
Role: collaborator
Detect and Infer the Severity of COPD by Intelligent Terminal Device
Role: collaborator
The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
Role: collaborator
Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia
Role: collaborator
Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
Role: collaborator
Mulltimodal Dynamic Risk Assessment Systems of Heart Failure in Patients With Myocardial Infarction.
Role: collaborator
EROSION II: OCT Guided PPCI in STEMI
Role: collaborator
ECG-guided Immediate Primary PCI for Culprit Vessel to Reduce Door to Device Time
Role: lead
Bleeding Risk Assessment System for Antithrombotic Therapy of ACS
Role: collaborator